Articles written in Journal of Chemical Sciences
Volume 132 All articles Published: 9 January 2020 Article ID 0020
This paper reports designing a series of new D-p-A topology-based metal-free organic dye molecules using ullazine and perylene by DFT methods. This work emphasizes the combination of ullazine analogs as donors and perylene dicarboxylic anhydride as an acceptor along with acetylene linker as p-bridgefor DSSC applications. The structural and optoelectronic properties of dyes before and after adsorption on to TiO2 semiconductor have been investigated. The screening of the designed dyes is carried out based on the energy gap (Eg), maximum absorption wavelength (kmax), light-harvesting efficiency (LHE), excited-state lifetime (s), the free energy of electron injection (DGinj) and regeneration (DGreg). DFT results reveal that the presence of ullazine analogs as a donor reduces the energy gap (Eg) and leads to red-shift in absorptionmaximum. Further, two different binding modes of dye molecules with (TiO2)38 cluster have been investigated to unravel the binding associated changes in the electronic structure. The results show that the completely dissociated bidentate bridging (CBB2) mode is more favorable, which contains two carboxylic groups.Findings emphasize the remarkable charge transfer characteristics which favors the fast electron injection from excited dye to the conduction band of TiO2. For the first time, this study provides comprehensive structural and electronic information combined with the Dye-TiO2 interactions for the development of perylene based dyes for DSSC applications
Volume 134 All articles Published: 22 April 2022 Article ID 0057 Regular Article
Exploring the new therapeutic indications of known drugs for treating COVID-19, popularly known as drug repurposing, is emerging as a pragmatic approach especially owing to the mounting pressure to control the pandemic. Targeting multiple targets with a single drug by employing drug repurposing known as the polypharmacology approach may be an optimised strategy for the development of effective therapeutics. In this study, virtual screening has been carried out on seven popular SARS-CoV-2 targets (3CLpro,PLpro, RdRp (NSP12), NSP13, NSP14, NSP15, and NSP16). A total of 4015 approved drugs were screened against these targets. Four drugs namely venetoclax, tirilazad, acetyldigitoxin, and ledipasvir have been selected based on the docking score, ability to interact with four or more targets and having a reasonably good number of interactions with key residues in the targets. The MD simulations and MM-PBSA studies showed reasonable stability of protein-drug complexes and sustainability of key interactions between the drugs with their respective targets throughout the course of MD simulations. The identified four drug molecules were also compared with the known drugs namely elbasvir and nafamostat. While the study has provided a detailed account of the chosen protein-drug complexes, it has explored the nature of seven important targets of SARSCoV-2 by evaluating the protein-drug complexation process in great detail.
Drug repurposing strategy against SARS-CoV2 drug targets. Computational analysis was performed to identify repurposable approved drug candidates against SARS-CoV2 using approaches such as virtual screening, molecular dynamics simulation and MM-PBSA calculations. Four drugs namely venetoclax, tirilazad, acetyldigitoxin, and ledipasvir have been selected as potential candidates.
Volume 135, 2023
Continuous Article Publishing mode
Click here for Editorial Note on CAP Mode